STAT Plus: Here’s a hypothesis: Lower doses of some cancer pills could save a lot of money
APSTOCK
Value-based prescribing is being explored as more patients experience financial toxicity caused by the rising prices for medicines.
Suscribirse a:
Enviar comentarios (Atom)
.png)
No hay comentarios:
Publicar un comentario